FDA lifts hold on Geron study

Geron announced today that the FDA has lifted a clinical hold placed on the company's Investigational New Drug (IND) application, allowing the Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury to proceed. Geron release